最低临床体能测试表现预测膝关节骨关节炎患者日行 6000 步:一项观察性研究。
Minimum Performance on Clinical Tests of Physical Function to Predict Walking 6,000 Steps/Day in Knee Osteoarthritis: An Observational Study.
机构信息
University of Delaware, Newark.
出版信息
Arthritis Care Res (Hoboken). 2018 Jul;70(7):1005-1011. doi: 10.1002/acr.23448. Epub 2018 May 6.
OBJECTIVE
Evidence of physical function difficulties, such as difficulty rising from a chair, may limit daily walking for people with knee osteoarthritis (OA). The purpose of this study was to identify minimum performance thresholds on clinical tests of physical function predictive to walking ≥6,000 steps/day. This benchmark is known to discriminate people with knee OA who develop functional limitation over time from those who do not.
METHODS
Using data from the Osteoarthritis Initiative, we quantified daily walking as average steps/day from an accelerometer (Actigraph GT1M) worn for ≥10 hours/day over 1 week. Physical function was quantified using 3 performance-based clinical tests: 5 times sit-to-stand test, walking speed (tested over 20 meters), and 400-meter walk test. To identify minimum performance thresholds for daily walking, we calculated physical function values corresponding to high specificity (80-95%) to predict walking ≥6,000 steps/day.
RESULTS
Among 1,925 participants (mean ± SD age 65.1 ± 9.1 years, mean ± SD body mass index 28.4 ± 4.8 kg/m , and 55% female) with valid accelerometer data, 54.9% walked ≥6,000 steps/day. High specificity thresholds of physical function for walking ≥6,000 steps/day ranged 11.4-14.0 seconds on the 5 times sit-to-stand test, 1.13-1.26 meters/second for walking speed, or 315-349 seconds on the 400-meter walk test.
CONCLUSION
Not meeting these minimum performance thresholds on clinical tests of physical function may indicate inadequate physical ability to walk ≥6,000 steps/day for people with knee OA. Rehabilitation may be indicated to address underlying impairments limiting physical function.
目的
身体功能障碍的证据,如从椅子上站起来有困难,可能会限制膝骨关节炎(OA)患者的日常行走。本研究的目的是确定身体功能临床测试中预测每日行走≥6000 步的最小表现阈值。众所周知,这个基准可以区分随着时间的推移会出现功能限制的膝骨关节炎患者和不会出现功能限制的患者。
方法
使用来自骨关节炎倡议的数据,我们通过佩戴加速度计(Actigraph GT1M)来量化日常行走,加速度计每天佩戴至少 10 小时,每周至少 1 天。身体功能通过 3 项基于表现的临床测试来量化:5 次坐站测试、行走速度(在 20 米内测试)和 400 米步行测试。为了确定每日行走的最小功能阈值,我们计算了与高特异性(80-95%)相对应的身体功能值,以预测每日行走≥6000 步。
结果
在 1925 名具有有效加速度计数据的参与者中(平均年龄 65.1±9.1 岁,平均体重指数 28.4±4.8kg/m,女性占 55%),54.9%的人每日行走≥6000 步。用于预测每日行走≥6000 步的身体功能高特异性阈值范围为 5 次坐站测试 11.4-14.0 秒,行走速度 1.13-1.26 米/秒,400 米步行测试 315-349 秒。
结论
在膝骨关节炎患者中,如果无法达到身体功能临床测试的这些最小表现阈值,可能表明其行走≥6000 步的身体能力不足。可能需要康复来解决限制身体功能的潜在障碍。